Olmesartan medoxomil (Compound)

Synonyms:Olmesartan medoxomil, 144689-63-4, Benicar, Olmetec, CS-866, Cs 866, UNII-6M97XTV3HD, C29H30N6O6, 6M97XTV3HD, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate, 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, NCGC00095136-01, Benevas, Olsertain, Olvance, (5-Methyl-2-oxo-1,3-dioxol-4-yl)Methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-iMidazole-5-carboxylate, (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate, Benicar (TN), Olmetec (TN), CS866, SR-05000001987, votume, Openvas, CS-866DM, CS-866RN, Olmesartanmedoxomil, olmesartan-medoxomil, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate, Olmesartan medoxomil [USAN:INN:BAN], KS-1182, Olmesartan (medoxomil), Spectrum_001944, Spectrum2_000506, Spectrum3_001676, Spectrum4_000740, Spectrum5_001556, DSSTox_CID_25924, DSSTox_RID_81226, DSSTox_GSID_45924, SCHEMBL16403, BSPBio_003491, GTPL591, KBioGR_001040, KBioSS_002498, 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester, MLS006010109, SPECTRUM1505205, SPBio_000431, Olmesartan medoxomil (Benicar), CHEMBL1200692, DTXSID9045924, CHEBI:31932, KBio2_002490, KBio2_005058, KBio2_007626, KBio3_002711, AOB3863, HMS1922L15, HMS2089K18, HMS2093K16, HMS3651E13, HMS3715N09, HMS3743O09, Olmesartan medoxomil (JP17/USP), Pharmakon1600-01505205, AMY22222, BCP05214, ZINC4149248, Tox21_111445, BDBM50442892, CCG-39596, MFCD00944911, NSC758924, s1604, STL451024, AKOS015894907, AKOS015914772, AC-1601, BCP9000555, CCG-221184, CS-0577, MCULE-2480015750, NSC 758924, NSC-758924, Olmesartan medoxomil, >=98% (HPLC), SB19327, NCGC00095136-02, NCGC00095136-03, NCGC00095136-09, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate, HY-17005, SMR002203616, SBI-0206741.P001, AB0012006, CAS-144689-63-4, FT-0601603, O0510, SW199650-2, D01204
Pubchem:PUBCHEM:130881
Id:130881
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Olmesartan medoxomil's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Olmesartan medoxomil.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Olmesartan medoxomil.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.